Logo

AQB

AquaBounty Technologies, Inc.

AQB

AquaBounty Technologies, Inc. • NASDAQ
$1.05 ▲ 10.33% (+0.10)
Market Cap $4.09 M
52w High $2.95
52w Low $0.47
Dividend Yield 0%
P/E -0.05
Volume 214
Outstanding Shares 3.88M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $1.412M ▼ $-1.381M ▲ 0% $-0.36 ▲ $-1.484M ▲
Q2-2025 $0 $1.769M ▲ $-3.373M ▼ 0% $-0.87 ▼ $-3.071M ▼
Q1-2025 $0 ▲ $1.26M ▼ $401.135K ▲ 0% ▼ $0.1 ▲ $969.448K ▲
Q4-2024 $-705.262K ▼ $47.904M ▲ $-84.116M ▼ 11.927K% ▲ $-21.77 ▼ $-48.585M ▼
Q3-2024 $47.812K $1.984M $-3.404M -7.12K% $-0.88 $-2.228M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $951.434K ▲ $24.174M ▼ $11.934M ▼ $12.24M ▼
Q2-2025 $729.569K ▼ $26.651M ▼ $13.037M ▲ $13.614M ▼
Q1-2025 $1.366M ▲ $29.434M ▼ $12.464M ▼ $16.97M ▲
Q4-2024 $230.362K ▼ $34.062M ▼ $18.221M ▲ $15.841M ▼
Q3-2024 $500.434K $117.785M $17.714M $100.072M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-980.039M ▲ $-1.651B ▼ $2.473B ▲ $-600M ▼ $221.865M ▲ $-1.651B ▼
Q2-2025 $-3.373B ▼ $-1.548B ▲ $911.563M ▼ $0 ▲ $-636.759M ▼ $-1.548B ▲
Q1-2025 $401.135K ▲ $-2.362B ▼ $3.721B ▲ $-232.194M ▼ $1.136B ▲ $-2.362B ▼
Q4-2024 $-84.116M ▼ $-1.163M ▲ $774.133K ▼ $124.389K ▲ $-270.072K ▼ $-1.376M ▲
Q3-2024 $-3.404M $-4.001M $8.683M $-4.91M $-227.905K $-4.675M

Revenue by Products

Product Q4-2023Q1-2024Q2-2024Q3-2024
Other Revenue
Other Revenue
 $0 ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement AquaBounty’s income statement shows a company that never really reached commercial scale. Over several years, it generated essentially no recurring revenue and relied on outside funding rather than sales. Losses have been consistent, reflecting high development and operating costs without a matching income stream. The apparent improvement in operating results in the most recent year is likely driven by one‑time gains from selling assets, not from a healthy, ongoing business. Underlying profitability from normal operations remains weak and unproven.

Balance Sheet

Balance Sheet The balance sheet has steadily shrunk, with total assets and shareholder equity falling sharply in the most recent period. Cash has dropped to very low levels, signaling limited financial flexibility. On the positive side, debt levels appear modest, so the company is not heavily leveraged. However, the small equity base and declining asset pool suggest the financial cushion is thin, and the business is now largely supported by asset sales rather than a growing asset base. Reverse stock splits over time also hint at past share price pressure and dilution for existing holders.

Cash Flow

Cash Flow Cash flow has been consistently negative, meaning the company has been burning cash year after year. Operating activities have not generated enough cash to cover basic expenses, indicating that the core business model has not yet been self‑sustaining. Historically, significant funds went into building facilities and capacity, which kept free cash flow deeply negative. More recently, investment spending has fallen as projects were halted or reversed, but free cash flow is still negative, and liquidity has depended heavily on financing and monetizing assets. Overall, the cash picture reflects a company in survival mode rather than one funding growth from its own operations.

Competitive Edge

Competitive Edge AquaBounty once held a unique position: it was the first company to gain approval to sell genetically engineered salmon for human consumption, supported by patents and regulatory clearances that others found hard to replicate. That regulatory and intellectual property advantage formed the core of its competitive moat. With the sale of its AquAdvantage salmon intellectual property and the shutdown of its own farms, that moat has largely disappeared. The company no longer controls the product that made it distinctive, and it has exited direct production, leaving it with limited visible competitive strength compared to traditional salmon producers and emerging aquaculture technologies. Its remaining edge is mainly in know‑how and experience, which is much easier for others to challenge than owned patents and operating assets.

Innovation and R&D

Innovation and R&D For years, AquaBounty was a genuine innovator, combining genetic engineering and land‑based aquaculture systems to create faster‑growing salmon raised in tightly controlled environments. It demonstrated strong technical capabilities in fish genetics, breeding, and recirculating aquaculture systems, and it broke important regulatory ground as the first approved genetically modified animal for food. However, financial strain has forced a major retreat: the company has sold off its flagship intellectual property and closed or sold core facilities. That dramatically reduces the value of its historical R&D investments and makes future innovation uncertain, as there are fewer resources and fewer strategic assets left to build on. Any ongoing role in innovation is now more likely to be advisory or licensing‑based rather than driven by in‑house, asset‑heavy R&D programs.

Summary

Overall, AquaBounty looks like a pioneering technology story that struggled to become a sustainable business. The company proved its science and achieved first‑of‑its‑kind regulatory approvals, but never established a solid revenue base and remained structurally unprofitable. Its financial position is now constrained, with a much smaller asset base, tight liquidity, and ongoing cash burn. Strategically, the sale of its key salmon intellectual property and exit from farming operations mark a fundamental shift—from a vertically integrated producer with a unique product to an entity searching for a new role. The company’s future depends on how effectively it can monetize remaining assets and know‑how, but the path forward is highly uncertain and no longer anchored by its original core product.

NEWS

October 28, 2025 · 8:00 AM UTC

AquaBounty Technologies Announces Third Quarter 2025 Financial Results

Read more